SynthesisBMC medicine2017

Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis.

Perrine Créquit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.